Valirx

VAL · AIM · Health Care · mcap £1.8m · 0.1p

Beta Briefing, track record and bull & bear case are not ready for Valirx yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 35 companies are already wired into a briefing: browse them.

Peel Hunt LLP 10 Nov – 13 Nov · 2 notices

9.5% → 10.0%

share price at the notices 0.2p · now 0.1p 10 Nov 2025 13 Nov 2025

Stephen Wolstenhulme 24 Nov – 5 Dec · 2 notices

5.8% → 3.0%

share price at the notices 0.2–0.3p · now 0.1p 24 Nov 2025 5 Dec 2025

Jaspal Singh 24 Nov – 8 Jan · 2 notices

8.0% → 3.0%

share price at the notices 0.2–0.4p · now 0.1p 24 Nov 2025 8 Jan 2026

Directors

purchase ValiRx PLC announced that Chief Executive Officer Mark Eccleston purchased 1,000,000 ordinary shares at 0.33 pence per share on 3 March 2026. This transaction increases his resultant interest in ordinary shares to 59,746 4 Mar 2026

award ValiRx PLC announced that all resolutions were passed at its Annual General Meeting, and the company has issued 577,500,000 Fundraising Warrants exercisable at 0.28 pence per Ordinary Share until the third anniversary of 17 Jul 2026

Company filings. Not investment advice.